Arkansas approved to ban SNAP recipients from using benefits for soda, candy
USDA Sec. Brooke Rollins (left) stands next to Gov. Sarah Huckabee Sanders as she announces Arkansas' request to exclude soda and candy from SNAP benefits on April 15, 2025. (Ainsley Platt/Arkansas Advocate)
Candy and sodas are coming off the menu for SNAP recipients in Arkansas, and rotisserie chickens are taking their place.
U.S. Secretary of Agriculture Brooke Rollins officially approved a waiver to allow Arkansas to ban its SNAP recipients from using their benefits to purchase certain types of food on Tuesday. Gov. Sarah Huckabee Sanders made the waiver request to the U.S. Department of Agriculture, which oversees the Supplemental Nutrition Assistance Program, when Rollins visited Little Rock in April.
The waiver will take effect July 1, 2026.
Sanders specifically asked the federal government to allow Arkansas to restrict SNAP participants from purchasing certain types of food and drink deemed unhealthy with their benefits, such as soda, juices with less than 50% natural juice and other 'unhealthy drinks,' along with 'confectionary products with flour and artificially sweetened candy.'
In their place, Sanders requested that Arkansas SNAP recipients be allowed to purchase rotisserie chickens with their food benefits.
Arkansas asks USDA to exclude soda, candy from state SNAP benefits
In an emailed press release Tuesday, Sanders said the approval 'sends a clear message' that Arkansas stands with the Trump administration to tackle the 'chronic disease epidemic' in the U.S.
'Arkansas leads the nation in getting unhealthy, ultra-processed foods off food stamps and helping our most vulnerable citizens lead healthier lives,' Sanders said.
The exclusion of soda and candy would not decrease overall SNAP benefits received by beneficiaries, Sanders said during Rollins' April visit, but would rather free up more of their benefits for healthier foods.
Arkansas was one of the first states to request the junk food waiver. Nebraska was the first to receive approval on May 20.
In a Monday night press release, the USDA said Rollins would host U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., Indiana Gov. Mike Braun and Sanders for 'a discussion about President [Donald] Trump's government wide effort to Make America Healthy Again.'
'America's governors have proudly answered the call to innovate by improving nutrition programs, ensuring better choices while respecting the generosity of the American taxpayer,' the Sanders release quoted Rollins as saying.
Since aligning himself with President Donald Trump last year after a failed presidential campaign, Kennedy has continued his criticisms of companies and foods he says contribute to Americans' poor health. It spawned the broader MAHA movement among conservatives, with GOP governors such as Sanders repeating Kennedy's warnings of a 'chronic disease epidemic' caused by food dyes and ultraprocessed foods.
Sanders' waiver request was made as Arkansas legislators considered — and ultimately approved — legislation that requires the Arkansas Department of Human Services, which oversees SNAP in the state, to apply for a junk food waiver over the objections of Arkansas Advocates for Children and Families, who said the requirement was a 'slippery slope in terms of debating what foods are healthy or not.'
A better way to address poor health outcomes would be to address root causes such as poverty and access to medical care, Christin Harper, AACF's policy director told legislators in April.
The food industry pushed back on Sanders' assertions that their products were driving a health crisis in April, with the National Confectioners Association calling the waiver 'misguided.' The NCA argued then that the 'candy purchasing patterns' of those who received SNAP benefits and those who didn't were 'basically equivalent.'
The American Beverage Association also pushed back on the arguments Sanders made in April, saying at the time that granting the waiver 'won't make one ounce of difference on health.'
The waiver decision comes after the USDA backed down on a demand to states that they provide a variety of personally-identifiable information on SNAP beneficiaries while lawsuits played out.
Arkansas shares certain SNAP applicant numbers with federal government
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
33 minutes ago
- Associated Press
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that LockeT sales for Q2 2025 are on track to be the highest to date. Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. Catheter Precision now has several US hospitals that are on track to issue more than $100,000 in purchase orders each for LockeT by the end of 2025. These hospitals include Montefiore (Bronx, NY), Eisenhower Health (Rancho Mirage, CA), and Overland Park Regional Medical Center (Overland Park, KS). As previously announced, LockeT received the CE Mark enabling sales in Europe. Catheter Precision has secured a new distributor in Italy and anticipates additional distributors in the coming days for Spain, Portugal and the UK and is actively searching for the right partner is other EU countries. David Jenkins, CEO of Catheter Precision said, 'We are excited about the upcoming activities, sales pipeline and expanded use by existing customer to increase revenue generated by LockeT. At this time, there is a live case scheduled on Monday, Juen 16 with a key opinion leader where he will demonstrate LockeT during an Italian symposium, increasing its awareness to the new market. As a company, we continue to focus on improving product awareness, increasing product usage and expanding our footprint into Europe.' About LockeT Catheter Precision's LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and has received CE Mark approval. About Catheter Precision Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Cautionary Note Regarding Forward-Looking Statements Statements in this press release may contain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to substantial risk and uncertainties. Forward-looking statements can be identified by words such as 'believe,' 'anticipate,' 'may,' 'might,' 'can,' 'could,' 'continue,' 'depends,' 'expect,' 'expand,' 'forecast,' 'intend,' 'predict,' 'plan,' 'rely,' 'should,' 'will,' 'may,' 'seek,' or the negative of these terms and other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements include, but are not limited to, statements regarding product evaluations at the hospital, and that the purchase order indicates that the hospital and its staff see the value and benefits that LockeT can bring and expectations regarding LockeT evaluations in the coming weeks. The Company's expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks and changes in circumstances, including but not limited to risks and uncertainties included under the caption 'Risk Factors' in the Company's Form 10-K filed with the SEC and available at The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. CONTACTS: At the Company David Jenkins 973-691-2000 [email protected] # # #
Yahoo
38 minutes ago
- Yahoo
Analysis-Kennedy's ouster of US vaccine advisers puts pharma ties under scrutiny
By Chad Terhune (Reuters) -U.S. Health Secretary Robert F. Kennedy Jr.'s surprise ouster of a national vaccine advisory board, claiming it was "plagued with persistent conflicts of interest," puts new scrutiny on the group that recommends which shots should be administered to the American public. Kennedy said most vaccine experts on the 17-member Advisory Committee on Immunization Practices (ACIP) have received "substantial funding" from drugmakers. He did not provide examples of conflicts of interest for any individual adviser or say how that may have influenced specific recommendations. Committee members say their work with the U.S. Centers for Disease Control and Prevention follows rigorous vetting of their financial ties. They must abstain from votes on any vaccine for which they have a conflict, as well as any rival to that vaccine or any product from the same manufacturer, according to CDC rules. The agency's website lists one of the departing panel members as recusing herself over such conflicts. "To determine that the whole (advisory board), all 17 members, have conflicts of interest, that has not been shown by the evidence," fired board member Dr. Oliver Brooks told Reuters. "However, the decisions that have been made (by Kennedy) undermine confidence in the process and in vaccines." Six of the vaccine advisers fired by Kennedy received a total of $80 or less from drugmakers from 2017 to 2023, according to a Reuters review of the Open Payments federal database of industry payments to healthcare providers. Seven other panel members received between $4,000 and $55,000 from drugmakers for consulting, speaking fees, travel or meals over the period 2017 to 2023. Two of those experts had also worked with other scientists in industry-funded research projects worth several millions of dollars. Brooks, retired chief medical officer at Watts Healthcare in Los Angeles and former president of the National Medical Association, received nearly $44,000 in general payments from Sanofi, according to the government records. Most of the payments occurred in 2017 and 2018, with nothing after 2020. Brooks became a vaccine adviser in 2021, and did not disclose any conflicts that would preclude him from voting. He said the panel's sole aim is "to prevent vaccine-preventable illness." Sanofi declined to comment. At least three vaccine advisers were not health professionals tracked by mandatory Open Payments reporting. KENNEDY'S CONFLICT Kennedy, who has spent years sowing doubts about vaccine safety and efficacy contrary to scientific evidence, faced questions from Congress about his own potential conflicts of interest during a confirmation hearing. Kennedy said he would divest his financial interest in litigation against Merck over its Gardasil vaccine, which prevents cancers caused by the human papillomavirus, to his non-dependent, adult son. In posts on X this week, Kennedy said he would share "examples of the historical corruption at ACIP" and announced eight new panel members. Four of them had received nominal reimbursement for meals, according to Open Payments, while the remainder recorded no payments or weren't covered by the database. A 2009 federal inspector general's report criticized the CDC for lax enforcement of disclosures among its advisory panels. New research shared with Reuters suggests conflicts have since declined among vaccine board members. "People are more aware of these issues on advisory committees, so they're facing greater scrutiny there," said Dr. Genevieve Kanter, an associate professor of public policy at the University of Southern California who has studied conflicts among government health advisers. Kanter's analysis of vaccine panel disclosures found that, on average, 43% of panel members facing decisions on specific vaccines declared conflicts in 2000 compared to 5%, on average, at meetings over the last 10 years. Kanter said it will also be important to understand how the vaccine advisers assembled by Kennedy are vetted for conflicts. They are due to meet at the end of June. "We don't want to replace one conflict with another set of conflicts," she said. "If someone has a financial interest in treatments that are believed to be alternatives to vaccines for certain conditions, we want to know that." DISCLOSURE RULES ACIP members are required to divest all stock in vaccine makers and stop any active consulting work for those companies before joining the panel. They can't accept travel or food from vaccine companies or collect product royalties. Similar restrictions apply to family members. Committee members can keep working on vaccine clinical trials funded by industry and those research grants can help cover their salaries. They are required to file annual disclosures and recuse themselves from votes when specific conflicts arise. "ACIP members ... are carefully screened for major conflicts of interest and selected through a lengthy process," said the California Department of Public Health, whose immunization chief, Dr. Robert Schechter, was fired from the panel by Kennedy. One of the fired panel members, Dr. Bonnie Maldonado, is a pediatric infectious diseases specialist at Stanford University who has led vaccine studies worldwide. She participated in research that received $4.65 million in funding from Pfizer, most of it spanning 2021 to 2023. The studies involved vaccines for COVID-19, RSV and other diseases. Maldonado also received general payments from drugmakers, including $26,465 from Pfizer and nearly $7,000 from Merck. Maldonado abstained from a vote on COVID vaccine recommendations in June 2024, declaring a conflict of interest. In October, she did participate in a COVID-related vote. Maldonado didn't respond to a request for comment. Noel Brewer, a professor of public health at the University of North Carolina, is not a clinician and therefore not included in Open Payments. In a 2017 research paper, he disclosed receiving research grants from Merck, Pfizer and GSK and serving on a paid advisory board for Merck. The disclosures did not give details on the payment amounts. Spokespeople for the three vaccine makers were not immediately available for comment.
Fox News
39 minutes ago
- Fox News
Medical experts warn 'Big Food' is fighting back against Ozempic with addictive items for sale
Ozempic and other weight-loss drugs may be cutting through "food noise," yet the junk food industry is only getting louder, some medical experts claim. "Ozempic is breaking the food addiction cycle – but Big Food isn't going down without a fight," Dr. Mark Hyman, an internationally recognized advocate for functional medicine, said in a recent Instagram post. "For decades, ultraprocessed foods have been engineered to hijack the brain's reward system – perfecting the 'bliss point' of sugar, salt and fat to keep people hooked," the physician also said. As Americans work to take hold of their health and wellness – and as the government cracks down on artificial food additives – the snack food industry appears to be evolving to outsmart both drugs and lifestyle changes, according to some observers. "Big Food isn't happy," Hyman continued, expressing his point of view. "Our food system is broken. It's built to create addictions, push ultraprocessed junk and profit off public health crises." Weight-loss and life coach Charles D'Angelo, based in St. Louis, Missouri, agreed with that assessment. "The food industry is one of many things evolving to outsmart our judgment sometimes," D'Angelo told Fox News Digital. "They are even outsmarting these medications and different health trends by engineering foods that bypass your hunger and can ultimately lead you to be more reactive than you otherwise would be." Fox News Digital reached out to Novo Nordisk, the manufacturer of Ozempic, for comment. Hyper-palatable foods (HPF) are designed with combinations of palatability-inducing ingredients, fat, sugar and carbohydrates that together enhance a food's deliciousness and produce an artificially rewarding eating experience, according to the National Institutes of Health (NIH). The Consumer Brands Association, based in Arlington, Virginia, represents the interests of the consumer-packaged goods (CPG) industry. "The makers of America's trusted household brands deliver safe products to consumers and innovate to provide them with healthier options," Sarah Gallo, senior vice president of product policy for the Consumer Brands Association, told Fox News Digital. "No industry is closer to the consumer than this one," she added. "For decades, food and beverage companies have taken their cues from consumers on what products they want in the marketplace to meet their dietary and health goals – whether it's options low in sugar, sodium and saturated fats, no artificial colors or low-carb, high-protein and high-fiber options." D'Angelo said that even without added ingredients, however, marketing campaigns often mislead consumers into purchasing and eating or drinking foods they think are healthful when they're not, D'Angelo said. "That's not nutrition. It's marketing." "They're not just selling junk food anymore," D'Angelo said. "How many things do you see when you go down the grocery store aisle that say high-protein or low-carb, but they're still ultraprocessed? And it's engineered to hook you. That's not nutrition. It's marketing." Gallo said her organization is aligned with the goal of radical transparency and aiding consumers in making informed choices. "The industry has been actively engaged in initiatives to improve nutritional information accessibility for over a decade," Gallo said. One initiative is Facts Up Front, a voluntary program that presents key nutritional information on the front of packaging, facilitating quick assessment by consumers. Additionally, the industry has introduced SmartLabel, allowing consumers to access detailed nutritional information via QR codes. For more Lifestyle articles, visit Gallo said the Consumer Brands Association "stands ready" to work with the federal government "to continue to ensure the analysis of safe ingredients and increase consumer transparency." She added, "It's also why we are working with Congress to ensure the [U.S. Food and Drug Administration] is properly resourced to carry out this important work and moving to mandatory notifications for new ingredients." "We need clarity, awareness and a complete shift in mindset to take back ownership of our choices." Still, D'Angelo said, misleading labels can give people a false sense of confidence in their personal choices. "I see how people are being conditioned subtly and repeatedly to trust marketing over their own inner signals, their own inner judgment," he said. "That's why we need more than just willpower or medications. We need clarity, awareness and a complete shift in mindset to take back ownership of our choices."
